A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non-small-cell lung cancer.
CANCER RESEARCH(2023)
关键词
oral egfr inhibitor,lung cancer,glioblastoma,small-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要